Argenica Therapeutics

About:

Argenica Therapeutics is a developing novel neuroprotective therapeutics to reduce brain damage after stroke

Website: https://argenica.com.au/

Description:

Argenica Therapeutics is a developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Total Funding Amount:

1.2M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nedlands, Western Australia, Australia

Founded Date:

2019-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2023-01-20

IPO Status:

Public

Industries: